Raloxifene Hydrochloride

gonadotropin releasing hormone 1 ; Homo sapiens







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28523264 Erratum to: Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density. 2017 Apr 1
2 28119898 Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density. 2016 Dec 2
3 17062721 Treatment-related osteoporosis in men with prostate cancer. 2006 Oct 15 1
4 16985877 Selective estrogen receptor modulators to prevent treatment-related osteoporosis. 2005 1
5 15292315 Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. 2004 Aug 1
6 12364422 Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 2002 Oct 4